# Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism

> **NCT02510612** · PHASE4 · UNKNOWN · sponsor: **Shaanxi Provincial People's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02510612
- **Lead sponsor:** Shaanxi Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510612, "Dexmedetomidine Affect Diabetic Patient's Glucose Metabolism". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02510612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*